The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients

NCT ID: NCT05165823

Last Updated: 2023-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-08

Study Completion Date

2023-07-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized controlled trial with 72 patients with hypertension examining the effects on blood pressure of sodium restriction and whether the blood analysis Salt-blood test is associated to a decrease in blood pressure. Patients will be randomized 2:1 to either sodium restriction or usual diet for 4 weeks. Baseline measures will be done before intervention and outcome measures after the 4 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension,Essential

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sodium restriction

Group Type EXPERIMENTAL

Sodium restriction

Intervention Type BEHAVIORAL

Participants will be guided in minimizing sodium intake. Guidance will be both oral and written. Bread with low sodium content will be offered to the participants.

Usual diet

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sodium restriction

Participants will be guided in minimizing sodium intake. Guidance will be both oral and written. Bread with low sodium content will be offered to the participants.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI ≤ 35 kg/m2
* Essential hypertension
* eGFR \> 15 ml/min/1,73m2
* Albumine-to-creatinine-ratio \< 500 mg/g
* Safe anticonception if women in childbearing age.
* Able to adhere to dietary regimen

Exclusion Criteria

* Secondary hypertension
* Clinically significant heart failure (NYHA 3-4)
* Clinically significant liver disease
* Diabetes mellitus (type 1 and 2)
* Active cancer (except skin cancer)
* Renal transplant
* Recent stroke, transcient ischemic attack or myocardial infarction (within 6 months)
* Proliferative glomerulonephritis or ANCA-related disease
* Continuous immunosuppressant treatment
* Pregnancy or lactation
* Alcohol abuse
* If the investigator finds the participant unfit to complete the project
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regional Hospital Holstebro

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Camilla Lundgreen Duus

Doctor, Ph.D.-student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Camilla Lundgreen Duus

Role: PRINCIPAL_INVESTIGATOR

University Clinic in Nephrology and Hypertension

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Clinic in Nephrology and Hypertension

Herning, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Duus CL, Nielsen SF, Hornstrup BG, Mose FH, Bech JN. Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. J Am Heart Assoc. 2024 Jun 18;13(12):e034632. doi: 10.1161/JAHA.124.034632. Epub 2024 Jun 6.

Reference Type DERIVED
PMID: 38842286 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLD-2-2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Salt and HMB Study
NCT05515900 UNKNOWN NA